Cargando…
Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey
BACKGROUND: This study aimed to assess the validity of the EQ-5D-5L in respondents with self-reported diabetes coming from a representative general population survey. METHODS: 2974 respondents from the general adult population of Poland, chosen with multi-stage random sampling, were surveyed with HR...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097836/ https://www.ncbi.nlm.nih.gov/pubmed/33952271 http://dx.doi.org/10.1186/s12955-021-01780-2 |
_version_ | 1783688393500131328 |
---|---|
author | Jankowska, Agnieszka Młyńczak, Katarzyna Golicki, Dominik |
author_facet | Jankowska, Agnieszka Młyńczak, Katarzyna Golicki, Dominik |
author_sort | Jankowska, Agnieszka |
collection | PubMed |
description | BACKGROUND: This study aimed to assess the validity of the EQ-5D-5L in respondents with self-reported diabetes coming from a representative general population survey. METHODS: 2974 respondents from the general adult population of Poland, chosen with multi-stage random sampling, were surveyed with HRQoL instruments (EQ-5D-5L, EQ VAS, SF-12, EQ-5D-3L) and a screening question about diabetes. To obtain EQ-5D index values, we used country-specific Polish value sets. We compared the instruments in terms of the ceiling effect, discriminatory power and frequency of individual health states. We evaluated construct validity in terms of known-groups validity and convergent validity of EQ-5D-5L dimensions and index values with other HRQoL measures. RESULTS: In respondents with diabetes (n = 247), the percentage reporting 'no problems' with EQ-5D-3L was reduced by 34.5% with the use of EQ-5D-5L (from 14.2% to 9.3%, respectively). A significant improvement in informativity was noticed in mobility and pain/discomfort dimensions (a relative increase of 23.1% and 22.7%, respectively). Known-groups construct validity analysis confirmed prior hypotheses—index scores were higher in the following groups: younger respondents, males, those taking no medication or oral antidiabetic drugs, and respondents with higher levels of education. The convergence between related EQ-5D-5L and EQ-5D-3L or SF-6D dimensions was stronger than between unrelated dimensions. The Bland–Altman analysis showed a mean difference between EQ-5D-5L and EQ-5D-3L, SF-6D, EQ VAS/100 index scores of 0.047, 0.165 and 0.231 respectively. CONCLUSIONS: Our results support the validity of the EQ-5D-5L descriptive system and EQ-5D-5L index, based on the directly measured value set in respondents with self-reported diabetes coming from the general population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-021-01780-2. |
format | Online Article Text |
id | pubmed-8097836 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80978362021-05-05 Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey Jankowska, Agnieszka Młyńczak, Katarzyna Golicki, Dominik Health Qual Life Outcomes Research BACKGROUND: This study aimed to assess the validity of the EQ-5D-5L in respondents with self-reported diabetes coming from a representative general population survey. METHODS: 2974 respondents from the general adult population of Poland, chosen with multi-stage random sampling, were surveyed with HRQoL instruments (EQ-5D-5L, EQ VAS, SF-12, EQ-5D-3L) and a screening question about diabetes. To obtain EQ-5D index values, we used country-specific Polish value sets. We compared the instruments in terms of the ceiling effect, discriminatory power and frequency of individual health states. We evaluated construct validity in terms of known-groups validity and convergent validity of EQ-5D-5L dimensions and index values with other HRQoL measures. RESULTS: In respondents with diabetes (n = 247), the percentage reporting 'no problems' with EQ-5D-3L was reduced by 34.5% with the use of EQ-5D-5L (from 14.2% to 9.3%, respectively). A significant improvement in informativity was noticed in mobility and pain/discomfort dimensions (a relative increase of 23.1% and 22.7%, respectively). Known-groups construct validity analysis confirmed prior hypotheses—index scores were higher in the following groups: younger respondents, males, those taking no medication or oral antidiabetic drugs, and respondents with higher levels of education. The convergence between related EQ-5D-5L and EQ-5D-3L or SF-6D dimensions was stronger than between unrelated dimensions. The Bland–Altman analysis showed a mean difference between EQ-5D-5L and EQ-5D-3L, SF-6D, EQ VAS/100 index scores of 0.047, 0.165 and 0.231 respectively. CONCLUSIONS: Our results support the validity of the EQ-5D-5L descriptive system and EQ-5D-5L index, based on the directly measured value set in respondents with self-reported diabetes coming from the general population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12955-021-01780-2. BioMed Central 2021-05-05 /pmc/articles/PMC8097836/ /pubmed/33952271 http://dx.doi.org/10.1186/s12955-021-01780-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Jankowska, Agnieszka Młyńczak, Katarzyna Golicki, Dominik Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey |
title | Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey |
title_full | Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey |
title_fullStr | Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey |
title_full_unstemmed | Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey |
title_short | Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey |
title_sort | validity of eq-5d-5l health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097836/ https://www.ncbi.nlm.nih.gov/pubmed/33952271 http://dx.doi.org/10.1186/s12955-021-01780-2 |
work_keys_str_mv | AT jankowskaagnieszka validityofeq5d5lhealthrelatedqualityoflifequestionnaireinselfreporteddiabetesevidencefromageneralpopulationsurvey AT młynczakkatarzyna validityofeq5d5lhealthrelatedqualityoflifequestionnaireinselfreporteddiabetesevidencefromageneralpopulationsurvey AT golickidominik validityofeq5d5lhealthrelatedqualityoflifequestionnaireinselfreporteddiabetesevidencefromageneralpopulationsurvey |